Immune Checkpoint Inhibitors Europe

Realise the next generation of immune checkpoint modulators by attending ICI Europe.
Event Dates
2015-11-16 - 2015-11-18
Organizer
Event contact title
Marketing Manager
Event contact first name
Katie
Event contact last name
Draper
Email
info@hansonwade.com
Event contact telephone number
+44 (0) 20 3141 8700
Description
Assembling industry thought-leaders, ICI Europe will distil the latest insights and more advanced science on developing next generation immune checkpoint modulators. Coined as miracle drugs, Opdivo and Keytruda are recently approved treatments in Europe. Coupled with the many encouraging ICIs in company pipelines, we are on the cusp of revolutionising cancer treatment. With market approval feeling more obtainable than ever, rivalry to develop the next miracle ICI is fierce. Everyone is racing to be next to market. However, development hurdles are preventing the realisation of this next generation of checkpoint blockades. The ICI Europe meeting will help drug developers tackle these challenges and see significant pipeline development in the next 6 months. Download the full event guide to view the full speaker faculty and presentations. Attend this meeting to access industry intelligence, helping you to: Effectively selective responsive patients Effective in less than 30% of treated patients and with spiralling treatment costs it is imperative to identify responsive patients. More than this, to improve our understanding of why. ICI Europe will give you a comprehensive understanding of CTCs as a clinically predictive biomarker for solid tumours. Hear how CTCs could stratify patients and predict the efficacy of immune checkpoint blockades. Translate into the clinic confidently using humanized mouse models Modelling the immune system is highly complex. Current ‘status quo’ immune-compromised tumour models provide insufficient data. ICI Europe will improve the clinical predictability of your ICI drugs by teaching you how to develop robust immuno-competent mouse models. Improve your preclinical efficacy testing and accelerate your preclinical pipeline into the clinic. Improve the efficacy of your drug using combination therapies Combination therapies offer your drug superior efficacy for larger patient populations and overcome cancer resistance. Currently there is a lack of understanding on how to combine therapies with ICIs, and which combinations offer the most promise. Through industry case studies you will learn explore combining ICIs with radiation, oncoloytic viruses, cancer vaccines and more. Attend ICI Europe to propel your immuno-oncology drug pipeline to clinical and commercial success.
Partner Voices
Overview: The award-winning Orange County Convention Center (OCCC) goes the extra mile to make every day extraordinary by offering customer service excellence and industry-leading partnerships. From their dedicated in-house Rigging team to their robust Exhibitor Services, The Center of Hospitality brings your imagination to life by helping you host unforgettable meetings and events. With more than 2 million square feet of exhibit space, world-class services and a dream destination, we are committed to making even the most ambitious conventions a reality. In October 2023, the Orange County Board of County Commissioners voted to approve allocating Tourist Development Tax funding for the $560 million Phase 5A completion of the OCCC. The Convention Way Grand Concourse project will include enhancements to the North-South Building, featuring an additional 60,000 square feet of meeting space, an 80,000- square-foot ballroom and new entry to the North-South Building along Convention Way. “We are thrilled to begin work on completing our North-South Building which will allow us to meet the growing needs of our clients,” said OCCC Executive Director Mark Tester. “As an economic driver for the community, this project will provide the Center with connectivity and meeting space to host more events and continue to infuse the local economy with new money and expanding business opportunities.” Amenities: The Center of Hospitality goes above and beyond by offering world-class customer service and industry-leading partnerships. From the largest convention center Wi-Fi network to custom LAN/WAN design, the Center takes pride in enhancing exhibitor and customer experience.  The OCCC is the exclusive provider of electricity (24-hour power at no additional cost), aerial rigging and lighting, water, natural gas and propane, compressed air, and cable TV services. Convenience The Center is at the epicenter of the destination, with an abundance of hotels, restaurants, and attractions within walking distance. Pedestrian bridges connect both buildings to more than 5,200 rooms and is within a 15-minute drive from the Orlando International Airport. The convenience of the location goes hand-in-hand with top notch service to help meet an event’s every need. Gold Key Members The OCCC’s Gold Key Members represent the best of the best when it comes to exceptional service and exclusive benefits for clients, exhibitors and guests. The Center’s Gold Key memberships with Universal Orlando Resort, SeaWorld Orlando and Walt Disney World greatly enhance meeting planner and attendee experiences offering world-renowned venues, immersive experiences and creative resources for their events. OCCC Events: This fiscal year, the OCCC is projected to host 168 events, 1.7 million attendees, and $2.9 billion in economic impact.  The Center’s top five events during their 2022-2023 fiscal year included:  AAU Jr. National Volleyball Championships 2023 200,000 Attendees $257 Million in Economic Impact MEGACON 2023 160,000 Attendees $205 Million in Economic Impact Open Championship Series 2023 69,500 Attendees $89 Million in Economic Impact Sunshine Classic 2023 42,000 Attendees $54 Million in Economic Impact Premiere Orlando 2023 42,000 Attendees $108 Million in Economic Impact